COVID-19 Updates

Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta Opens a Sickle Cell Disease Outpatient Clinic in Columbus


ATLANTA (March 27, 2019) – The Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta announced today it will expand its Sickle Cell Disease and Hematology programs to include outpatient services beginning March 27. The Columbus Sickle Cell Clinic will be operated by Aflac Cancer and Blood Disorders Center pediatric hematologists and nurses with the goal of better serving children and families in the Columbus area.

The outpatient clinic, located across from the Piedmont Columbus Regional Midtown campus, will provide clinical services for the more than 150 patients in the Columbus area. Four primary hematologists will operate the clinic, and staff will communicate with the patients’ primary care and hospital doctors to coordinate care locally and with services in the Atlanta hospital–including transfusions, surgery and special tests–when needed.

“We are excited to expand our services to current Aflac sickle cell and hematology patient families living near Columbus who have been making the long trip to and from our Atlanta clinics,” said Karen Wasilewski, MD, Medical Director of the Aflac Cancer and Blood Disorders Center, and one of the four hematologists on staff in the Columbus clinic. “This clinic increases access to high-quality preventative care and health-maintenance essential to the well-being of our patients with sickle cell disease. We are looking forward to making a difference in the lives of new patients and families in the area who were previously not able to commute to meet with our sickle cell disease care team.”

Funding to operate the new outpatient clinic has been provided by Piedmont Columbus Regional Foundation through the Ben Koon Pediatric Oncology Endowment Fund. The fund was named in honor of Ben Koon, grandson of Robert and Joyce Koon, who established the fund to benefit others in need. Children’s and Piedmont Columbus Regional announced a formal affiliation agreement in April 2018 with the goal of furthering high-quality pediatric care.

“Our family experienced pain, struggle and expense due to the lack of treatment in Columbus and we know there are other sickle cell disease patients with no pediatric hematologist available to treat them,” Robert Koon said. “This clinic will provide support, treatment and hope for many children in the Columbus region. Our grandson would be very pleased to know he was the motivation to make this clinic possible.”

“As home to our corporate headquarters, the City of Columbus is special to us, so the opening of this outpatient clinic is meaningful to our entire Aflac family committed to helping defeat childhood cancer and blood disorders, and in particular, sickle cell disease,” said Dan Amos, Chairman and CEO at Aflac Inc. “We could not be more proud of how many patients and families we’ve impacted through our long-term partnership with Children’s and how many more we’ll reach in the future with sickle cell disease services now in our own backyard.”

The clinic will operate on the fourth and fifth Wednesday of every month from 9 a.m. to 2 p.m. To make an appointment for an established Aflac Cancer and Blood Disorders Center sickle cell disease patient, call 404-785-3561. To make a patient referral to the newly opened Columbus Sickle Cell Disease Clinic, fax the following documents to 404-785-3790: patient demographics, insurance information, reason for referral and clinical notes.

For more information:

Allyson Wright

Public Relations, Manager

404-785-7253

Allyson.Wright2@choa.org

Aflac Cancer and Blood Disorders Center of Children’s

The Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta is a national leader among childhood cancer, hematology, and blood and marrow transplant programs, serving children and young adults. Recognized as one of the top childhood cancer centers in the country by U.S. News & World Report, the Aflac Cancer and Blood Disorders Center cares for more than 500 newly diagnosed cancer patients and treats nearly 2,000 unique sickle cell disease patients each year. Ranked number one in the country for COG therapeutic clinical trial enrollment, our program offers patients access to more than 450 clinical trials, including 14 innovative Aflac Cancer and Blood Disorders Center investigator-initiated trials. Visit choa.org/cancer for more information.

About AFLAC

Aflac Incorporated (NYSE: AFL) is a Fortune 500 company, helping provide protection to more than 50 million people through its subsidiaries in Japan and the U.S., where it is a leading supplemental insurer by paying cash fast when policyholders get sick or injured. For more than six decades, insurance policies of Aflac Incorporated’s subsidiaries have given policyholders the opportunity to focus on recovery, not financial stress. Aflac Life Insurance Japan is the leading provider of medical and cancer insurance in Japan where it insures 1 in 4 households. Through its trailblazing One Day PaySM initiative in the United States, for eligible claims, Aflac can process, approve and electronically send funds to claimants for quick access to cash in just one business day. For 13 consecutive years, Aflac has been recognized by Ethisphere as one of the World's Most Ethical Companies. In 2018, Fortune magazine recognized Aflac as one of the 100 Best Companies to Work for in America for the 20th consecutive year, and in 2019, Fortune included Aflac on its list of World’s Most Admired Companies for the 18th time. To find out more about One Day PaySM and learn how to get help with expenses health insurance doesn’t cover, get to know us at aflac.com.

* Required fields